Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response to SARS-CoV2 Vaccinations in Treated MS Patients Compared to Controls

NCT05060354 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05060354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response to SARS-CoV2 Vaccinations in Treated MS Patients Compared to Controls
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
September 28, 2023
Enrollment
159 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, multiple sclerosis